🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

27 recruiting trials

for Focal Seizure

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) NCT05716100Phase 398 sites📍 Little Rock📍 Downey📍 Los Angeles Xenon Pharmaceuticals Inc. · Tests: XEN1101, Placebo A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures NCT07233239Phase 124 sites📍 Phoenix📍 La Jolla📍 New Haven Jazz Pharmaceuticals · Tests: CBD-OS Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures NCT07594119Phase 313 sites📍 Huntsville📍 Bentonville📍 Colorado Springs Rapport Therapeutics Inc. · Tests: RAP-219, RAP-219, Placebo Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain NCT06716801n/a1 site📍 Paris Aziende Chimiche Riunite Angelini Francesco S.p.A · Tests: Cenobamate Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy NCT05518578Phase 210 sites📍 Jacksonville📍 Miami📍 Randwick Supernus Pharmaceuticals, Inc. · Tests: SPN-817 An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures NCT06908356Phase 211 sites📍 Phoenix📍 Miami Lakes📍 Bethesda Praxis Precision Medicines · Tests: 30mg PRAX-628 Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)) NCT05135091Phase 335 sites📍 Birmingham📍 Phoenix📍 Tucson Neurona Therapeutics · Tests: NRTX-1001, NRTX-1001, Sham Comparator A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures NCT06967012Phase 41 site📍 Nantong Affiliated Hospital of Nantong University · Tests: Oral Zonisamide Therapy Changes in Attentional Control After a Focal Seizure. NCT06466681n/a1 site📍 Lille University Hospital, Lille · Tests: All included subjects Prospective Study of Eslicarbazepine in Adults With Focal-Onset Seizures NCT07793396n/a1 site📍 Lahore King Edward Medical University · Tests: Eslicarbazepine acetate Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients NCT05784805NA1 site📍 New Haven Yale University · Tests: PLIFU Epilepsy Learning Healthcare System (ELHS) NCT06265103n/a13 sites📍 Phoenix📍 Los Angeles📍 Los Angeles Epilepsy Foundation of America · Tests: Clinical care and quality improvement Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1 NCT07563881Phase 318 sites📍 Birmingham📍 Palmdale📍 Gulf Breeze Rapport Therapeutics Inc. · Tests: RAP-219, RAP-219, Placebo A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy NCT06388707Phase 1, Phase 23 sites📍 Palo Alto📍 Boston📍 Charlottesville NaviFUS Corporation · Tests: NaviFUS System Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables NCT07012148EARLY Phase 13 sites📍 Scottsdale📍 Jacksonville📍 Rochester Mayo Clinic · Tests: UNEEG SubQ device, seizure forecasts, nasal diazepam, Preventative Medication (PM) Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients NCT04653012NA1 site📍 Paris Institut National de la Santé Et de la Recherche Médicale, … · Tests: Intracranial macro-microelectrode recording Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement NCT06241924NA1 site📍 Bordeaux University Hospital, Bordeaux · Tests: High Resolution Electroencephalogram (EEG-HR), Stereo-electro-encephalography (SEEG) RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures NCT06798896Phase 263 sites📍 Phoenix📍 Phoenix📍 Tucson Supernus Pharmaceuticals, Inc. · Tests: SPN-817, Placebo Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases NCT07130786Phase 21 site📍 Boston Ayal A. Aizer, MD · Tests: Levetiracetam (Keppra) A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures NCT07219407Phase 27 sites📍 Boise📍 Rochester📍 New York Rapport Therapeutics Inc. · Tests: RAP-219 Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy NCT07680842NA1 site📍 San Francisco University of California, San Francisco · Tests: Target optimization using LIFU, Serial LIFU stimulation REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization NCT06922175n/a10 sites📍 Freiburg im Breisgau📍 Hamburg📍 Kork Aziende Chimiche Riunite Angelini Francesco S.p.A A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy NCT06492720NA1 site📍 Taipei NaviFUS Corporation · Tests: Focused ultrasound (FUS) treatment Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy NCT02531880Phase 11 site📍 Bethesda National Institute of Neurological Disorders and Stroke (NI… · Tests: Mangafodipir, Gadolinium Efficacy of Probenecid on Cluster Seizures During Anti Seizure Medication Withdrawal in Presurgical Focal Epilepsy Video-EEG Monitoring NCT07318870Phase 22 sites📍 Paris📍 Paris Fondation Ophtalmologique Adolphe de Rothschild · Tests: Probenecid, Placebo Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology NCT06388161n/a1 site📍 Hangzhou Shen Chun-Hong SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures NCT07141329Phase 21 site📍 Port Charlotte Supernus Pharmaceuticals, Inc. · Tests: SPN-817
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy